nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A. Denver Russell
|
Denyer, Stephen |
|
2005 |
165-166 |
10 |
p. 1441-1442 2 p. |
artikel |
2 |
Advancements in adenoviral based virotherapy for ovarian cancer
|
Matthews, Kellie S. |
|
2009 |
165-166 |
10 |
p. 836-841 6 p. |
artikel |
3 |
Amino acids as promoieties in prodrug design and development
|
Vig, Balvinder S. |
|
2013 |
165-166 |
10 |
p. 1370-1385 16 p. |
artikel |
4 |
Antibiotic resistance—the problem intensifies
|
Levy, Stuart B. |
|
2005 |
165-166 |
10 |
p. 1446-1450 5 p. |
artikel |
5 |
Antiepileptic drug delivery
|
Baum, Larry |
|
2012 |
165-166 |
10 |
p. 885-886 2 p. |
artikel |
6 |
Antimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microflora
|
Yan, S.Steve |
|
2004 |
165-166 |
10 |
p. 1497-1521 25 p. |
artikel |
7 |
Bacterial resistance to antibiotics: Active efflux and reduced uptake
|
Kumar, Ayush |
|
2005 |
165-166 |
10 |
p. 1486-1513 28 p. |
artikel |
8 |
Bacterial resistance to antibiotics: Enzymatic degradation and modification
|
Wright, Gerard D. |
|
2005 |
165-166 |
10 |
p. 1451-1470 20 p. |
artikel |
9 |
Bacterial resistance to antibiotics: Modified target sites
|
Lambert, Peter A. |
|
2005 |
165-166 |
10 |
p. 1471-1485 15 p. |
artikel |
10 |
Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems
|
Winzenburg, Gesine |
|
2004 |
165-166 |
10 |
p. 1453-1466 14 p. |
artikel |
11 |
Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems?
|
Smith, Anthony W. |
|
2005 |
165-166 |
10 |
p. 1539-1550 12 p. |
artikel |
12 |
Cerebral expression of drug transporters in epilepsy
|
Aronica, Eleonora |
|
2012 |
165-166 |
10 |
p. 919-929 11 p. |
artikel |
13 |
Chemical properties of antiepileptic drugs (AEDs)
|
Bialer, Meir |
|
2012 |
165-166 |
10 |
p. 887-895 9 p. |
artikel |
14 |
Clinical development of PEGylated recombinant staphylokinase (PEG–Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction
|
Moreadith, Randall W |
|
2003 |
165-166 |
10 |
p. 1337-1345 9 p. |
artikel |
15 |
Clinical impact and relevance of antibiotic resistance
|
French, G.L. |
|
2005 |
165-166 |
10 |
p. 1514-1527 14 p. |
artikel |
16 |
Companion animal physiology and dosage form performance
|
Sutton, Steven C |
|
2004 |
165-166 |
10 |
p. 1383-1398 16 p. |
artikel |
17 |
Corrigendum to “Real-time multiple-particle tracking: Applications to drug and gene delivery” [Advanced Drug Delivery Reviews 57(2005)63–78]
|
Suh, Junghae |
|
2005 |
165-166 |
10 |
p. 1551- 1 p. |
artikel |
18 |
Curb challenges of the “Trojan Horse” approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
|
Huang, Yongzhuo |
|
2013 |
165-166 |
10 |
p. 1299-1315 17 p. |
artikel |
19 |
Current challenges in clinical management of endometrial cancer
|
Montejo, Michael |
|
2009 |
165-166 |
10 |
p. 883-889 7 p. |
artikel |
20 |
Current oral and non-oral routes of antiepileptic drug delivery
|
Anderson, Gail D. |
|
2012 |
165-166 |
10 |
p. 911-918 8 p. |
artikel |
21 |
Current status and potential application of ISCOMs in veterinary medicine
|
Morein, Bror |
|
2004 |
165-166 |
10 |
p. 1367-1382 16 p. |
artikel |
22 |
CYP2A6 genetic variation and potential consequences
|
Xu, Chun |
|
2002 |
165-166 |
10 |
p. 1245-1256 12 p. |
artikel |
23 |
CYP2C9 allelic variants: ethnic distribution and functional significance
|
Xie, Hong-Guang |
|
2002 |
165-166 |
10 |
p. 1257-1270 14 p. |
artikel |
24 |
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases
|
Edwards III, Carl K |
|
2003 |
165-166 |
10 |
p. 1315-1336 22 p. |
artikel |
25 |
Driving delivery vehicles with ultrasound
|
Ferrara, Katherine W. |
|
2008 |
165-166 |
10 |
p. 1097-1102 6 p. |
artikel |
26 |
Drug delivery for in vitro fertilization: Rationale, current strategies and challenges
|
Janát-Amsbury, Margit M. |
|
2009 |
165-166 |
10 |
p. 871-882 12 p. |
artikel |
27 |
Editorial
|
Ghandehari, Hamidreza |
|
2013 |
165-166 |
10 |
p. 1283- 1 p. |
artikel |
28 |
Editorial Board
|
|
|
2009 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
29 |
Editorial Board
|
|
|
2013 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
30 |
Editorial Board
|
|
|
2003 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
31 |
Editorial Board
|
|
|
2002 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
32 |
Editorial Board
|
|
|
2004 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
33 |
Editorial Board
|
|
|
2008 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
34 |
Editorial Board
|
|
|
2005 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
35 |
Editorial Board
|
|
|
2012 |
165-166 |
10 |
p. ii- 1 p. |
artikel |
36 |
Endometrial Cancer—current state of the art therapies and unmet clinical needs: The role of surgery and preoperative radiographic assessment
|
Hunn, Jessica |
|
2009 |
165-166 |
10 |
p. 890-895 6 p. |
artikel |
37 |
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview
|
Mignani, Serge |
|
2013 |
165-166 |
10 |
p. 1316-1330 15 p. |
artikel |
38 |
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations
|
Hackett, Michael J. |
|
2013 |
165-166 |
10 |
p. 1331-1339 9 p. |
artikel |
39 |
Fetal gene therapy: Opportunities and risks
|
Wagner, Anna M. |
|
2009 |
165-166 |
10 |
p. 813-821 9 p. |
artikel |
40 |
filler CEP BW
|
|
|
2003 |
165-166 |
10 |
p. I- 1 p. |
artikel |
41 |
Fusion protein linkers: Property, design and functionality
|
Chen, Xiaoying |
|
2013 |
165-166 |
10 |
p. 1357-1369 13 p. |
artikel |
42 |
Gene therapy of benign gynecological diseases
|
Hassan, Memy H. |
|
2009 |
165-166 |
10 |
p. 822-835 14 p. |
artikel |
43 |
Genetic contribution to variable human CYP3A-mediated metabolism
|
Lamba, Jatinder K |
|
2002 |
165-166 |
10 |
p. 1271-1294 24 p. |
artikel |
44 |
Guide to Authors
|
|
|
2003 |
165-166 |
10 |
p. 1347-1350 4 p. |
artikel |
45 |
Guide to Authors
|
|
|
2002 |
165-166 |
10 |
p. 1353-1355 3 p. |
artikel |
46 |
Guide to Authors
|
|
|
2004 |
165-166 |
10 |
p. 1523-1526 4 p. |
artikel |
47 |
Host factors affecting antiepileptic drug delivery—Pharmacokinetic variability
|
Johannessen Landmark, Cecilie |
|
2012 |
165-166 |
10 |
p. 896-910 15 p. |
artikel |
48 |
Hypoxia targeting gene expression for breast cancer gene therapy
|
Lee, Minhyung |
|
2009 |
165-166 |
10 |
p. 842-849 8 p. |
artikel |
49 |
Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers
|
Bae, Younsoo |
|
2009 |
165-166 |
10 |
p. 768-784 17 p. |
artikel |
50 |
Intestinal drug transporters: An overview
|
Estudante, Margarida |
|
2013 |
165-166 |
10 |
p. 1340-1356 17 p. |
artikel |
51 |
Issues and challenges in developing long-acting veterinary antibiotic formulations
|
Sun, Yichun |
|
2004 |
165-166 |
10 |
p. 1481-1496 16 p. |
artikel |
52 |
Issues and challenges in developing ruminal drug delivery systems
|
Vandamme, Th.F |
|
2004 |
165-166 |
10 |
p. 1415-1436 22 p. |
artikel |
53 |
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|
van der Meel, Roy |
|
2013 |
165-166 |
10 |
p. 1284-1298 15 p. |
artikel |
54 |
Liposomes in ultrasonic drug and gene delivery
|
Huang, Shao-Ling |
|
2008 |
165-166 |
10 |
p. 1167-1176 10 p. |
artikel |
55 |
Low-frequency sonophoresis: Current status and future prospects
|
Ogura, Makoto |
|
2008 |
165-166 |
10 |
p. 1218-1223 6 p. |
artikel |
56 |
Mechanisms of antimicrobial resistance: opportunities for new targeted therapies
|
Poole, Keith |
|
2005 |
165-166 |
10 |
p. 1443-1445 3 p. |
artikel |
57 |
Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development
|
Majumdar, Soumyajit |
|
2004 |
165-166 |
10 |
p. 1437-1452 16 p. |
artikel |
58 |
Micelles and nanoparticles for ultrasonic drug and gene delivery
|
Husseini, Ghaleb A. |
|
2008 |
165-166 |
10 |
p. 1137-1152 16 p. |
artikel |
59 |
Microbubbles in ultrasound-triggered drug and gene delivery
|
Hernot, Sophie |
|
2008 |
165-166 |
10 |
p. 1153-1166 14 p. |
artikel |
60 |
Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception
|
Rose, Susan |
|
2009 |
165-166 |
10 |
p. 808-812 5 p. |
artikel |
61 |
Novel methods of antiepileptic drug delivery — Polymer-based implants
|
Halliday, Amy J. |
|
2012 |
165-166 |
10 |
p. 953-964 12 p. |
artikel |
62 |
Novel nanomedicine-based MRI contrast agents for gynecological malignancies
|
Mody, Vicky V. |
|
2009 |
165-166 |
10 |
p. 795-807 13 p. |
artikel |
63 |
Novel target sites in bacteria for overcoming antibiotic resistance
|
Black, Michael T. |
|
2005 |
165-166 |
10 |
p. 1528-1538 11 p. |
artikel |
64 |
OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
|
Elstad, Nancy L. |
|
2009 |
165-166 |
10 |
p. 785-794 10 p. |
artikel |
65 |
Oral delivery of medications to companion animals: palatability considerations
|
Thombre, Avinash G |
|
2004 |
165-166 |
10 |
p. 1399-1413 15 p. |
artikel |
66 |
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
|
Hafner, Annina M. |
|
2013 |
165-166 |
10 |
p. 1386-1399 14 p. |
artikel |
67 |
Pegaspargase: a review of clinical studies
|
Graham, Michael L. |
|
2003 |
165-166 |
10 |
p. 1293-1302 10 p. |
artikel |
68 |
Pegvisomant in the treatment of acromegaly
|
Parkinson, C |
|
2003 |
165-166 |
10 |
p. 1303-1314 12 p. |
artikel |
69 |
PEGylation of growth hormone-releasing hormone (GRF) analogues
|
Esposito, P |
|
2003 |
165-166 |
10 |
p. 1279-1291 13 p. |
artikel |
70 |
Peptide and protein pegylation II – clinical evaluation
|
|
|
2003 |
165-166 |
10 |
p. 1259-1260 2 p. |
artikel |
71 |
Pharmacogenetics: Is the right drug for the right patient sufficient?
|
Brouwer, Kim L.R |
|
2002 |
165-166 |
10 |
p. 1243-1244 2 p. |
artikel |
72 |
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
|
|
|
2002 |
165-166 |
10 |
p. 1241-1242 2 p. |
artikel |
73 |
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
|
Tirona, Rommel G |
|
2002 |
165-166 |
10 |
p. 1343-1352 10 p. |
artikel |
74 |
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
|
Caliceti, Paolo |
|
2003 |
165-166 |
10 |
p. 1261-1277 17 p. |
artikel |
75 |
Potential applications of chitosan in veterinary medicine
|
Şenel, Sevda |
|
2004 |
165-166 |
10 |
p. 1467-1480 14 p. |
artikel |
76 |
Publisher`s Note
|
|
|
2003 |
165-166 |
10 |
p. v- 1 p. |
artikel |
77 |
Response of contrast agents to ultrasound
|
Sboros, Vassilis |
|
2008 |
165-166 |
10 |
p. 1117-1136 20 p. |
artikel |
78 |
Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport
|
Potschka, Heidrun |
|
2012 |
165-166 |
10 |
p. 943-952 10 p. |
artikel |
79 |
Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition
|
Suzuki, Hiroshi |
|
2002 |
165-166 |
10 |
p. 1311-1331 21 p. |
artikel |
80 |
siRNA delivery systems for cancer treatment
|
Oh, Yu-Kyoung |
|
2009 |
165-166 |
10 |
p. 850-862 13 p. |
artikel |
81 |
Sustained release veterinary parenteral products
|
Medlicott, Natalie J |
|
2004 |
165-166 |
10 |
p. 1345-1365 21 p. |
artikel |
82 |
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
|
Fromm, Martin F |
|
2002 |
165-166 |
10 |
p. 1295-1310 16 p. |
artikel |
83 |
Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5
|
Adachi, Masashi |
|
2002 |
165-166 |
10 |
p. 1333-1342 10 p. |
artikel |
84 |
The Role of Gene- and Drug Delivery in women's health - Unmet clinical needs and future opportunities
|
Janát-Amsbury, Margit M. |
|
2009 |
165-166 |
10 |
p. 767- 1 p. |
artikel |
85 |
The transport of antiepileptic drugs by P-glycoprotein
|
Zhang, Chunbo |
|
2012 |
165-166 |
10 |
p. 930-942 13 p. |
artikel |
86 |
Ultrasonic gene and drug delivery to the cardiovascular system
|
Mayer, Christian R. |
|
2008 |
165-166 |
10 |
p. 1177-1192 16 p. |
artikel |
87 |
Ultrasound, cavitation bubbles and their interaction with cells
|
Wu, Junru |
|
2008 |
165-166 |
10 |
p. 1103-1116 14 p. |
artikel |
88 |
Ultrasound for drug and gene delivery to the brain
|
Hynynen, Kullervo |
|
2008 |
165-166 |
10 |
p. 1209-1217 9 p. |
artikel |
89 |
Ultrasound in drug and gene delivery
|
Pitt, William G. |
|
2008 |
165-166 |
10 |
p. 1095-1096 2 p. |
artikel |
90 |
Ultrasound mediated delivery of drugs and genes to solid tumors
|
Frenkel, Victor |
|
2008 |
165-166 |
10 |
p. 1193-1208 16 p. |
artikel |
91 |
Veterinary drug delivery: Part VI
|
Rathbone, Michael J |
|
2004 |
165-166 |
10 |
p. 1339-1344 6 p. |
artikel |
92 |
Women and heart disease — Physiologic regulation of gene delivery and expression: Bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease
|
Yockman, James W. |
|
2009 |
165-166 |
10 |
p. 863-870 8 p. |
artikel |